A new study found that therapy dogs reduce anxiety in children visiting the emergency department, with both child-reported and parent-reported anxiety scores decreasing more in those who interacted with a...
A new randomized clinical trial found that psilocybin therapy reduced symptoms of depression in frontline clinicians affected by the COVID-19 pandemic, with effects lasting up to 6 months.
A recent study suggests that an 8-week online mindfulness program may help alleviate dyspnea in patients with interstitial lung disease, a condition often resistant to conventional treatments.
A randomized, placebo-controlled trial found that executive working memory training leads to significant behavioral improvements in adolescents with attention-deficit/hyperactivity disorder.
A new study led by the Congenital Heart Initiative explores quality of life, mental health, and physical activity outcomes in a large cohort of adults with congenital heart disease.
A recent clinical trial demonstrates that both group and self-paced telehealth mindfulness-based interventions can potentially enhance pain-related function and biopsychosocial outcomes in veterans with...
In a pilot study, acupuncture reduced ocular pain and inflammation while improving mental well-being and tear stability in patients with dry eye disease.
A randomized trial found that incorporating stress-relieving therapies, such as walking and essential oils, into standard irritable bowel syndrome care significantly enhanced quality of life, reduced...
Researchers conducted a randomized trial to evaluate the impact of mindfulness-based stress reduction on depression and quality of life in older adults living with HIV and cognitive impairment.
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
